Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881539 · ClinicalTrials.gov registry record · NA
CBD, Immune Function, and Neural Health
A NA study, sponsored by University of Northern Colorado.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04881539 is a NA study that has completed, run by University of Northern Colorado. The registered enrollment target is 50 participants.
The verdict
NCT04881539, a NA study, has completed, sponsored by University of Northern Colorado.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Chronic inflammation, which is defined as a persistent, low-grade inflammatory response within the body, is associated with many of the negative health conditions which are prevalent in our society today. It is most well-known for its role in the progression of diseases including obesity, metabolic syndrome, cancer, cardiovascular disease, and diabetes. Chronic inflammation is also linked to many of the underlying factors associated with disease development including perturbations in sleep, and mental health status such as depression, anxiety, fatigue, and quality of life. Natural killer cells, commonly referred to as NK cells, are a subset of white blood cells that play an important role in the coordination of inflammation in the body. Although many interventions aimed at controlling chronic inflammation and enhancing NK cell number and activity have been explored, relatively few have been administered without significant barriers. Cannabidiol (CBD), a non-psychoactive hemp derivative, is a potential, attractive therapeutic target. However, there is very little information in humans that addresses the potential of CBD to improve your health and immune function. The overall goal of this study is to explore the effects of 8-weeks of CBD supplementation on mental and physical health, sleep measures, and NK cell number and cytotoxic function. Specific Aim 1. Explore the effect of 8-weeks of CBD administration on sleep measures as well as measures of mental and physical health in conjunction with measurements of NK cell number and function.
Interventions
- DIETARY_SUPPLEMENT Cannabidiol (CBD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2022-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04881539
The ClinicalTrials.gov registry entry for NCT04881539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Northern Colorado, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabidiol (CBD) is the first listed.
NCT04881539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04881539 about?
NCT04881539 is a clinical study titled "CBD, Immune Function, and Neural Health". Chronic inflammation, which is defined as a persistent, low-grade inflammatory response within the body, is associated with many of the negative health conditions which are prevalent in our society today. It is most well-known for its role in the progression of diseases including obesity, metabolic ...
What is the current status of trial NCT04881539?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-05-15. Estimated completion is 2022-03-18.
What interventions are being tested in trial NCT04881539?
The interventions under investigation include: Cannabidiol (CBD) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04881539?
This trial is sponsored by University of Northern Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.